![Silvia Noiman](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Silvia Noiman
Direttore/Membro del Consiglio presso
Vico Therapeutics BV
Profilo
Silvia Noiman is the founder.
Founded Predix Pharmaceuticals Holdings, Inc. in 2000 as Senior Vice President.
Founded Imel Biotherapeutics, Inc. in 2019 as Chief Executive Officer.
Founded cCAM Biotherapeutics Ltd. in 2010 as Executive Chairman.
Founded Eloxx Pharmaceuticals Ltd. in 2013 as Chief Executive Officer & Director.
Founded Eloxx Pharmaceuticals, Inc. in 2017 as Director.
Dr. Noiman is also the founder of Predix Pharmaceuticals Ltd. Current job at Vico Therapeutics BV as Director since 2020.
Former job at Quiet Therapeutics Ltd. as Executive Chairman from 2010 to 2015.
Former job at Pontifax Management Co. Ltd. as Venture Partner.
Education at Tel-Aviv University with a doctorate degree.
Posizioni attive di Silvia Noiman
| Società | Posizione | Inizio |
|---|---|---|
Vico Therapeutics BV
 Vico Therapeutics BV BiotechnologyHealth Technology Develops ribonucleic acid modulating therapies | Direttore/Membro del Consiglio | 29/07/2020 |
Precedenti posizioni note di Silvia Noiman
| Società | Posizione | Fine |
|---|---|---|
Imel Biotherapeutics, Inc.
 Imel Biotherapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Develops treatment for mitochondrial disease | Amministratore Delegato | 01/04/2024 |
| ELOXX PHARMACEUTICALS, INC. | Fondatore | 01/04/2021 |
cCAM Biotherapeutics Ltd.
 cCAM Biotherapeutics Ltd. Pharmaceuticals: MajorHealth Technology Discovers, develops and markets novel immunotherapy to treat cancer | Fondatore | 01/07/2015 |
Predix Pharmaceuticals Holdings, Inc.
 Predix Pharmaceuticals Holdings, Inc. Pharmaceuticals: MajorHealth Technology Discovers and developes novel, highly selective, small-molecule drugs | Fondatore | - |
Pontifax Management Co. Ltd.
 Pontifax Management Co. Ltd. Investment ManagersFinance Pontifax invests in companies located in Israel. The firm focuses on the companies operating in the fields of life sciences & health sector. The firm provide financing for early and growth stage capital transactions. | Investitore di Private Equity | - |
Formazione di Silvia Noiman
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
14
Relazioni di 1° grado
10
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 10 |
|---|---|
Tel-Aviv University
 Tel-Aviv University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Predix Pharmaceuticals Holdings, Inc.
Predix Pharmaceuticals Holdings, Inc. Pharmaceuticals: MajorHealth Technology Discovers and developes novel, highly selective, small-molecule drugs | Health Technology |
Predix Pharmaceuticals Ltd. | |
Pontifax Management Co. Ltd.
Pontifax Management Co. Ltd. Investment ManagersFinance Pontifax invests in companies located in Israel. The firm focuses on the companies operating in the fields of life sciences & health sector. The firm provide financing for early and growth stage capital transactions. | Finance |
cCAM Biotherapeutics Ltd.
cCAM Biotherapeutics Ltd. Pharmaceuticals: MajorHealth Technology Discovers, develops and markets novel immunotherapy to treat cancer | Health Technology |
Quiet Therapeutics Ltd.
 Quiet Therapeutics Ltd. Medical SpecialtiesHealth Technology Develops a proprietary nanoparticle-based delivery system for the targeted delivery of chemotherapy and anti-inflammatory drugs | Health Technology |
Eloxx Pharmaceuticals Ltd.
 Eloxx Pharmaceuticals Ltd. BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company that develops novel genetic therapies | Health Technology |
Eloxx Pharmaceuticals, Inc.
 Eloxx Pharmaceuticals, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company that discovers and develops therapeutics to treat cystic fibrosis, inherited retinal disorders and other diseases | Health Technology |
Vico Therapeutics BV
Vico Therapeutics BV BiotechnologyHealth Technology Develops ribonucleic acid modulating therapies | Health Technology |
Imel Biotherapeutics, Inc.
Imel Biotherapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Develops treatment for mitochondrial disease | Commercial Services |
